Posted inComunicati
Biocon’s Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE BENGALURU, India, Sept. 22, 2026 /PRNewswire/ -- Biocon Biologics Limited, a…









